Influenza, Human  >>  Fluzone High-Dose Quadrivalent (influenza vaccine)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
NCT01430819: Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults

Completed
4
300
US
Influenza Virus Vaccine: Fluzone® 2011-2012 Formulation, Fluzone® 2011-2012 Formulation, Influenza Virus Vaccine: Fluzone® High-Dose 2011-2012 Formulation, Fluzone® High-Dose 2011-2012 Formulation
Sanofi Pasteur, a Sanofi Company
Influenza
02/12
02/12
NCT01691339: Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.

Completed
4
200
US
Influenza Virus Vaccine: Fluzone® 2012-2013 Formulation, Fluzone® (2012-2013 Formulation), Influenza Virus Vaccine: Fluzone® Intradermal 2012-2013 Formulation, Fluzone® Intradermal (2012-2013 Formulation), Influenza Virus Vaccine: Fluzone® High-Dose 2012-2013 Formulation, Fluzone® High-Dose (2012-2013 Formulation)
Sanofi Pasteur, a Sanofi Company
Influenza
11/12
02/13
NCT01427309: A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

Completed
4
31989
US, Canada
High Dose Trivalent Inactivated Influenza Vaccine, Fluzone® High Dose, Trivalent Inactivated Influenza Vaccine, Fluzone®
Sanofi Pasteur, a Sanofi Company
Influenza
05/13
11/13
NCT01946438: Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults

Completed
4
208
US
Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),, Fluzone® Quadrivalent, Influenza Virus Vaccine, Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),, Fluzone® Intradermal, Influenza Virus Vaccine, Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation), Fluzone® High-Dose, Influenza Virus Vaccine
Sanofi Pasteur, a Sanofi Company
Influenza
12/13
07/14
NCT02258334: Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults

Completed
4
208
US
Fluzone® Quadrivalent vaccine, 2014-2015 formulation, Fluzone® Quadrivalent vaccine, Fluzone I®ntradermal vaccine, 2014-2015 formulation, Fluzone® Intradermal vaccine, Fluzone High Dose vaccine, 2014-2015 formulation, Fluzone® High Dose, vaccine
Sanofi Pasteur, a Sanofi Company
Influenza
11/14
12/14

Download Options